Invention Grant
US08796244B2 Imidazopyridine derivatives as inhibitors of receptor tyrosine kinases
有权
咪唑并吡啶衍生物作为受体酪氨酸激酶的抑制剂
- Patent Title: Imidazopyridine derivatives as inhibitors of receptor tyrosine kinases
- Patent Title (中): 咪唑并吡啶衍生物作为受体酪氨酸激酶的抑制剂
-
Application No.: US12997754Application Date: 2009-06-12
-
Publication No.: US08796244B2Publication Date: 2014-08-05
- Inventor: Valerio Berdini , Maria Grazia Carr , Miles Stuart Congreve , Martyn Frederickson , Charlotte Mary Griffiths-Jones , Christopher Charles Frederick Hamlett , Andrew Madin , Christopher William Murray , Rajdeep Kaur Benning , Gordon Saxty , Emma Vickerstaffe , Brian John Williams , Andrew James Woodhead , Steven John Woodhead , Eddy Jean Edgard Freyne , Tom Cornelis Hortense Govaerts , Patrick René Angibaud
- Applicant: Valerio Berdini , Maria Grazia Carr , Miles Stuart Congreve , Martyn Frederickson , Charlotte Mary Griffiths-Jones , Christopher Charles Frederick Hamlett , Andrew Madin , Christopher William Murray , Rajdeep Kaur Benning , Gordon Saxty , Emma Vickerstaffe , Andrew James Woodhead , Steven John Woodhead , Eddy Jean Edgard Freyne , Tom Cornelis Hortense Govaerts , Patrick René Angibaud , Marian Williams
- Applicant Address: GB Cambridge
- Assignee: Astex Therapeutics Ltd
- Current Assignee: Astex Therapeutics Ltd
- Current Assignee Address: GB Cambridge
- Agency: Heslin Rothenberg Farley & Mesiti P.C.
- Priority: GB0810902.7 20080613
- International Application: PCT/EP2009/057318 WO 20090612
- International Announcement: WO2009/150240 WO 20091217
- Main IPC: A61K31/5025
- IPC: A61K31/5025 ; C07D413/02
Abstract:
The invention relates to new bicyclic heterocyclic derivative compounds, to pharmaceutical compositions comprising the compounds and to the use of the compounds in the treatment of diseases, e.g. cancer.
Public/Granted literature
- US20120208791A1 IMIDAZOPYRIDINE DERIVATIVES AS INHIBITORS OF RECEPTOR TYROSINE KINASES Public/Granted day:2012-08-16
Information query
IPC分类:
